{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:48:39Z","timestamp":1764604119937,"version":"3.45.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["1401-2-96-59269"],"award-info":[{"award-number":["1401-2-96-59269"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.intimp.2025.114297","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T08:01:23Z","timestamp":1739865683000},"page":"114297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dysregulated CDKN2A-MDM2-p53 axis in B cell of systemic lupus erythematosus"],"prefix":"10.1016","volume":"150","author":[{"given":"Amin","family":"Azizan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Tahereh","family":"Faezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Alikhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Vojgani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Enayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Vodjgani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2025.114297_bb0005","first-page":"997","article-title":"Systemic lupus erythematosus: One year in review 2023","volume":"41","author":"Zucchi","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114297_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.55563\/clinexprheumatol\/nolysy","article-title":"One year in review 2022: systemic lupus erythematosus","volume":"40","author":"Zucchi","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114297_bb0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cden.2013.06.003","article-title":"Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management","volume":"57","author":"Fortuna","year":"2013","journal-title":"Dent. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.intimp.2025.114297_bb0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.rdc.2021.04.006","article-title":"B cells in systemic lupus erythematosus: From disease mechanisms to targeted therapies","volume":"47","author":"Canny","year":"2021","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.intimp.2025.114297_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/1744666X.2023.2145281","article-title":"B cell depletion and inhibition in systemic lupus erythematosus","volume":"19","author":"Krustev","year":"2023","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114297_bb0030","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/1744666X.2017.1259068","article-title":"Improving B-cell depletion in systemic lupus erythematosus and rheumatoid arthritis","volume":"13","author":"Mota","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"24","key":"10.1016\/j.intimp.2025.114297_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246231","article-title":"B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments","volume":"20","author":"Yap","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.114297_bb0040","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0961203308089402","article-title":"Hormonal regulation of B-cell function and systemic lupus erythematosus","volume":"17","author":"Cohen-Solal","year":"2008","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.intimp.2025.114297_bb0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clim.2012.11.006","article-title":"B cell elimination in systemic lupus erythematosus","volume":"146","author":"Furtado","year":"2013","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.114297_bb0050","first-page":"2216","article-title":"Characterisation of T and B cell receptor repertoire in patients with systemic lupus erythematosus","volume":"41","author":"Hou","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"issue":"14","key":"10.1016\/j.intimp.2025.114297_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12144848","article-title":"Efficacy and safety of new B cell-targeted biologic agent for the treatment of systemic lupus erythematosus: A systematic review and Meta-analysis","volume":"12","author":"G\u00f3mez-Urquiza","year":"2023","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.114297_bb0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/art.40396","article-title":"Review: abnormal B cell development in systemic lupus erythematosus: What the genetics tell us","volume":"70","author":"Karrar","year":"2018","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2025.114297_bb0065","first-page":"9","article-title":"B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools","author":"Parodis","year":"2022","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.114297_bb0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.autrev.2008.06.002","article-title":"Immune complex clearance by complement receptor type 1 in SLE","volume":"8","author":"Kavai","year":"2008","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.intimp.2025.114297_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076578","article-title":"Advances in the pathogenesis and treatment of systemic lupus erythematosus","volume":"24","author":"Accapezzato","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2025.114297_bb0080","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.autrev.2007.01.017","article-title":"Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus","volume":"6","author":"Kavai","year":"2007","journal-title":"Autoimmun. Rev."},{"issue":"1 Suppl 1","key":"10.1016\/j.intimp.2025.114297_bb0085","first-page":"119","article-title":"Evidence for an immune complex disorder in systemic lupus erythematosus (SLE)","volume":"2","author":"McCluskey","year":"1982","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.intimp.2025.114297_bb0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12016-020-08820-7","article-title":"B cell aberrance in lupus: the ringleader and the solution","volume":"62","author":"Nie","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114297_bb0095","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1186\/ar1009","article-title":"B cell abnormalities in systemic lupus erythematosus","volume":"5","author":"Grammer","year":"2003","journal-title":"Arthritis Res. Ther."},{"issue":"23","key":"10.1016\/j.intimp.2025.114297_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236021","article-title":"Multiple functions of B cells in the pathogenesis of systemic lupus erythematosus","volume":"20","author":"Ma","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2025.114297_bb0105","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1681\/ASN.2011010045","article-title":"Mdm2 promotes systemic lupus erythematosus and lupus nephritis","volume":"22","author":"Allam","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"15","key":"10.1016\/j.intimp.2025.114297_bb0110","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2165\/00003495-200666150-00004","article-title":"B-cell-targeted therapy for systemic lupus erythematosus","volume":"66","author":"Sabahi","year":"2006","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.intimp.2025.114297_bb0115","first-page":"182","article-title":"B cell biology and dysfunction in SLE","volume":"65","author":"Anolik","year":"2007","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2025.114297_bb0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.blre.2017.03.001","article-title":"p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hell","volume":"31","author":"Tessoulin","year":"2017","journal-title":"Blood Rev."},{"issue":"4","key":"10.1016\/j.intimp.2025.114297_bb0125","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/1535-7163.MCT-12-0904","article-title":"Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2","volume":"12","author":"van Leeuwen","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.114297_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13048-019-0479-3","article-title":"Overexpression of CCDC69 activates p14(ARF)\/MDM2\/p53 pathway and confers cisplatin sensitivity","volume":"12","author":"Cui","year":"2019","journal-title":"J. Ovarian Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.114297_bb0135","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood.V99.4.1411","article-title":"p14(ARF) nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways","volume":"99","author":"S\u00e1nchez-Aguilera","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2025.114297_bb0140","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/cancers3010994","article-title":"Role of p53 in cell death and human cancers","volume":"3","author":"Ozaki","year":"2011","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2025.114297_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2010.06.008","article-title":"Systemic lupus erythematosus and increased risk to develop B cell malignancies: Role of the p200-family proteins","volume":"133","author":"Veeranki","year":"2010","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2025.114297_bb0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s42358-023-00320-4","article-title":"TP53 and p21 (CDKN1A) polymorphisms and the risk of systemic lupus erythematosus","volume":"63","author":"Macedo","year":"2023","journal-title":"Adv. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114297_bb0155","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.0904-2512.2004.00044.x","article-title":"p53 gene status and expression of p53, MDM2, and p14ARF proteins in ameloblastomas","volume":"33","author":"Kumamoto","year":"2004","journal-title":"J. Oral Pathol. Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.114297_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092125","article-title":"The role of p53 signaling in colorectal Cancer","volume":"13","author":"Liebl","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.intimp.2025.114297_bb0165","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jcp.24976","article-title":"p14(ARF) prevents proliferation of Aneuploid cells by inducing p53-dependent apoptosis","volume":"231","author":"Veneziano","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114297_bb0170","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1191\/096120399680411317","article-title":"The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: Strengths, weaknesses, and opportunities for improvement","volume":"8","author":"Smith","year":"1999","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.intimp.2025.114297_bb0175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000076130","article-title":"B lymphocyte selection and survival in systemic lupus","volume":"133","author":"Liossis","year":"2004","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114297_bb0180","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.biocel.2009.10.011","article-title":"The role of B cells in lupus pathogenesis","volume":"42","author":"Nashi","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2025.114297_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1155421","article-title":"B cell activation via immunometabolism in systemic lupus erythematosus","volume":"14","author":"Iwata","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114297_bb0190","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000527213","article-title":"Aberrant B-cell activation in systemic lupus erythematosus","volume":"8","author":"Kang","year":"2022","journal-title":"Kidney Dis (Basel)"},{"issue":"4","key":"10.1016\/j.intimp.2025.114297_bb0195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/08830185.2013.786712","article-title":"Aberrant B cell selection and activation in systemic lupus erythematosus","volume":"32","author":"Kil","year":"2013","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.114297_bb0200","article-title":"B-cell activating factor targeted therapy and lupus","volume":"14 Suppl 4(Suppl 4):S2","author":"Boneparth","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2025.114297_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.903075","article-title":"Recent findings on the role of wild-type and mutant p53 in cancer development and therapy","volume":"9","author":"Babamohamadi","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.intimp.2025.114297_bb0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.169.1.5","article-title":"Cutting edge: Molecular portrait of human autoimmune Disease1","volume":"169","author":"Maas","year":"2002","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114297_bb0215","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1191\/0961203306lu2332oa","article-title":"Gene expression studies in systemic lupus erythematosus","volume":"15","author":"Mandel","year":"2006","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.intimp.2025.114297_bb0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13148-015-0063-7","article-title":"The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus","volume":"7","author":"Luo","year":"2015","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.intimp.2025.114297_bb0225","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.molimm.2018.01.003","article-title":"DNA induction of MDM2 promotes proliferation of human renal mesangial cells and alters peripheral B cells subsets in pediatric systemic lupus erythematosus","volume":"94","author":"Zhang","year":"2018","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114297_bb0230","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7555\/JBR.27.20130030","article-title":"The MDM2-p53 pathway revisited","volume":"27","author":"Nag","year":"2013","journal-title":"J. Biomed. Res."},{"issue":"14","key":"10.1016\/j.intimp.2025.114297_bb0235","first-page":"993","article-title":"MDM2, an introduction","volume":"1","author":"Iwakuma","year":"2003","journal-title":"Mol. Cancer Res."},{"issue":"14","key":"10.1016\/j.intimp.2025.114297_bb0240","first-page":"1009","article-title":"Cell cycle regulatory functions of the human oncoprotein MDM2","volume":"1","author":"Deb","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.intimp.2025.114297_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/963568","article-title":"Autoantibody to MDM2: a potential serological marker of systemic lupus erythematosus","volume":"2015","author":"Liu","year":"2015","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.intimp.2025.114297_bb0250","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/abbs\/gmt147","article-title":"The regulation of MDM2 oncogene and its impact on human cancers","volume":"46","author":"Zhao","year":"2014","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"issue":"3","key":"10.1016\/j.intimp.2025.114297_bb0255","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1073\/pnas.0405495102","article-title":"The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma","volume":"102","author":"Slack","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"36","key":"10.1016\/j.intimp.2025.114297_bb0260","doi-asserted-by":"crossref","first-page":"30468","DOI":"10.1074\/jbc.M112.373738","article-title":"Transcription factor NFAT1 activates the mdm2 oncogene independent of p53","volume":"287","author":"Zhang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.114297_bb0265","doi-asserted-by":"crossref","unstructured":"Zhou JX, Lee CH, Qi CF, Wang H, Naghashfar Z, Abbasi S, Morse HC, 3rd. IFN regulatory factor 8 regulates MDM2 in germinal center B cells. J. Immunol. 2009;183(5):3188\u201394.","DOI":"10.4049\/jimmunol.0803693"},{"issue":"28","key":"10.1016\/j.intimp.2025.114297_bb0270","doi-asserted-by":"crossref","first-page":"29841","DOI":"10.1074\/jbc.M401488200","article-title":"PTEN regulates Mdm2 expression through the P1 promoter","volume":"279","author":"Chang","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.intimp.2025.114297_bb0275","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","article-title":"The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2","volume":"17","author":"Stott","year":"1998","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.intimp.2025.114297_bb0280","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/MCB.22.1.196-206.2002","article-title":"ARF function does not require p53 stabilization or Mdm2 relocalization","volume":"22","author":"Korgaonkar","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114297_bb0285","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tcb.2010.02.007","article-title":"p53 and ARF: unexpected players in autophagy","volume":"20","author":"Balaburski","year":"2010","journal-title":"Trends Cell Biol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114297_bb0290","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood.2020008276","article-title":"B-cell receptor signaling and genetic lesions in TP53 and CDKN2A\/CDKN2B cooperate in Richter transformation","volume":"138","author":"Chakraborty","year":"2021","journal-title":"Blood"},{"issue":"35","key":"10.1016\/j.intimp.2025.114297_bb0295","doi-asserted-by":"crossref","first-page":"36698","DOI":"10.1074\/jbc.M312305200","article-title":"Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc","volume":"279","author":"Datta","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.114297_bb0300","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1101\/sqb.2005.70.050","article-title":"Regulation of the Arf\/p53 tumor surveillance network by E2F","volume":"70","author":"Iaquinta","year":"2005","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114297_bb0305","doi-asserted-by":"crossref","first-page":"A160","DOI":"10.1289\/ehp.114-a160","article-title":"Epigenetics: the science of change","volume":"114","author":"Weinhold","year":"2006","journal-title":"Environ. Health Perspect."},{"issue":"20","key":"10.1016\/j.intimp.2025.114297_bb0310","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1101\/gad.13.20.2670","article-title":"INK4a\/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53","volume":"13","author":"Schmitt","year":"1999","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.intimp.2025.114297_bb0315","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.immuni.2020.06.013","article-title":"An integrated multi-omic single-cell atlas of human B cell identity","volume":"53","author":"Glass","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114297_bb0320","article-title":"LP-210\u00e2 Peripheral blood b-cell subsets in patients with systemic lupus erythematosus. Lupus","volume":"10(Suppl 1):null","author":"Tatyana","year":"2023","journal-title":"Sci. Med."},{"key":"10.1016\/j.intimp.2025.114297_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110968","article-title":"B cell subsets-related biomarkers and molecular pathways for systemic lupus erythematosus by transcriptomics analyses","volume":"124","author":"Song","year":"2023","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:20:19Z","timestamp":1763785219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925002875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":65,"alternative-id":["S1567576925002875"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114297","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulated CDKN2A-MDM2-p53 axis in B cell of systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114297"}}